Search Results 1001-1010 of 18162 for monoclonal antibody

  1. Combination of Serabelisib and Insulin Suppressing Diet in Subjects With Advanced Solid Tumors with PIK3CA Mutations - Mayo Clinic

    For monoclonal antibody therapy, the subject is < 1 half-life or <4 weeks from the last dose. 7. Chronic, systemically administered glucocorticoids in doses ...

  2. A Study to Evaluate Budesonide in Patients with Immune Mediated Enteropathies - Mayo Clinic

    ... monoclonal antibodies, alpha-4 beta-7 integrin inhibiting monoclonal antibody, interleukin 12/23 inhibiting monoclonal antibody, JAK inhibitors.

  3. A Study Of JNJ-90014496 In Participants With B-Cell Non-Hodgkin Lymphoma - Mayo Clinic

    ... monoclonal antibody; Relapsed or refractory disease defined as 1 or more of the following: Stable disease or Progressive disease (PD) as best response to ...

  4. Evaluation of ALD403 (Eptinezumab) in the Prevention of Chronic Migraine - Mayo Clinic

    Receipt of any monoclonal antibody treatment (within or outside a clinical trial) within 6 months before screening. Previously dosed with ALD403 or any ...

  5. Evaluation of Laboratory Methods for Detecting Auto Antibodies to Complement Proteins - Mayo Clinic

    The goal of this study is to validate testing to be performed in the clinical immunology lab and have a source of positive patient sera. These tests include:.

  6. A Study To Evaluate The Safety, Tolerability, And Effects On Blood And Urine Markers Of Single Ascending Dose Of GSK4771261 In Healthy Participants And Participants With Autosomal Dominant Polycystic Kidney Disease - Mayo Clinic

    Significant allergy to humanized monoclonal antibodies. Clinically significant multiple or severe drug allergies, or severe post-treatment hypersensitivity ...

  7. Treatment Of Antibody-Mediated Rejection (ABMR) With CarBel - Mayo Clinic

    About this study. The purpose of this study is to see: 1. If using these two drugs (carfilzomib and belatacept) together is safe

  8. Arthritis Clinical Trials

    ... Monoclonal Antibody, Administered Subcutaneously, in Patients With Active Rheumatoid Arthritis Despite Anti-TNF-Alpha Therapy (SIRROUND-T) Rochester, MN. The ...

  9. Sharing Mayo Clinic: An uncommon antibody, a life restored

    Sophisticated laboratory testing solved a medical riddle and finally got Jori Pearson back on his feet, doing what he loves. Jori Pearson was a 39-year-old ...

  10. A Study Of JNJ-69086420, An Actinium-225-Labeled Antibody Targeting Human Kallikrein-2 (HK2) For Advanced Prostate Cancer - Mayo Clinic

    A Study Of JNJ-69086420, An Actinium-225-Labeled Antibody Targeting Human Kallikrein-2 (HK2) For Advanced Prostate Cancer · More about research at Mayo Clinic.